To quantitatively compare the extent of posterior capsule opacification (PCO) after polymethylmethacrylate (PMMA), silicone, and soft acrylic intraocular lens implantation.
Patients and Methods
A total of 240 eyes from 240 patients undergoing implant surgery were randomized into 3 groups based on the type of lens implanted: PMMA, silicone, and soft acrylic. The density value of PCO in 185 eyes was quantitated approximately 2 years after surgery by a new measurement method using the Scheimpflug videophotography system.
Twenty-one eyes (30.4%) in the PMMA group, 4 (5.7%) in the silicone group, and 2 (2.7%) in the acrylic group had already undergone Nd:YAG laser posterior capsulotomy. The mean ± SD PCO values were 26.3 ± 12.2 computer-compatible tape steps (CCT) in the PMMA group, 12.0 ± 8.3 CCT in the silicone group, and 16.0 ± 10.3 CCT in the acrylic group. The PCO value in the PMMA group was significantly greater than that in the silicone or acrylic group (P<.001). The visual acuity loss in the PMMA group was also greater than that in the silicone or acrylic group (P<.001).
Based on the PCO value and capsulotomy rate, the PCO was more extensive with the PMMA lens than with either the silicone or soft acrylic lens, which led to visual acuity loss.
EVEN IN MODERN cataract surgery, posterior capsule opacification (PCO) is still the most common postoperative complication.1 It is well known that PCO is caused by the regeneration and extracellular matrix production of the residual lens epithelial cells.2-7 To prevent PCO, various kinds of drugs have been applied to suppress the activity of the lens epithelial cells.8-14 However, the reducing effect of these drugs on PCO remains only speculative since the quantification of PCO has yet to be established.
We recently developed a new measurement method of PCO using the Scheimpflug videophotography system.15 Using this method, the opacification density in the central posterior capsule area can be measured. We also confirmed this method to have an excellent intraobserver and interobserver reproducibility.16
The incidence of PCO has also been reported to differ based on the optic material of the implanted intraocular lens (IOL) with regard to the Nd:YAG capsulotomy rate.17-19 Recently, surgeons have reported less PCO with soft acrylic IOLs,20,21 because of its adhesive quality to the lens capsule.22,23
The purpose of this study was to quantitatively compare the extent of PCO after polymethylmethacrylate (PMMA), silicone, and soft acrylic lens implantation. We also compared the visual acuity loss due to PCO between the eyes that were implanted with 3 different kinds of IOLs.
Two hundred forty cataractous eyes in 240 patients who were scheduled to undergo phacoemulsification and IOL implant surgery were originally enrolled in this study. The preoperative exclusion criteria were as follows: cataracts with causes other than age-related changes, a history of ocular surgery or inflammation, eyes with pseudoexfoliation syndrome or retinal morbidity, eyes in diabetic patients, and eyes with a small pupillary diameter after a full dilation measuring less than 6.0 mm. All enrolled eyes were randomly assigned by the sealed envelope method to 1 of the 3 groups based on the type of IOL and included the PMMA group (MZ60BD, Alcon Surgical, Fort Worth, Tex), the silicone group (SI-30NB, Allergan Medical Optics, Irvine, Calif), and the soft acrylic group (MA60BM, Alcon Surgical). The MZ60BD is a 1-piece PMMA IOL with a 6.0-mm optic. The SI-30NB has a high refractive silicone 6.0-mm optic and polypropylene loops. The MA60BM has a soft acrylic 6.0-mm optic and PMMA loops.
Informed consent was obtained before surgery from all patients participating in this study. All operations were performed by a single surgeon (K.H.). The surgical procedures used in this study have all been previously described.24 In brief, the continuous curvilinear capsulorhexis, measuring about 5.5 mm in diameter, was accomplished using a bent 25-gauge needle. After a hydrodissection, endocapsular phacoemulsification of the nucleus and cortical aspiration was performed. Next, the lens capsule was inflated with 1% hyaluronate sodium, and the IOLs were inserted into the capsular bag. Finally, using a push-and-pull hook, the surgeon carefully confirmed whether the IOLs were accurately implanted in the lens capsule.
An examination to quantitate the PCO using the Anterior Eye Segment Analysis System (EAS-1000; Nidek, Gamagori, Japan) was then performed approximately 2 years after surgery. The measurement method of the density value of PCO with the EAS-1000 system has been described in a previous study.15 In brief, the examiner first took Scheimpflug slit images of the implanted IOL at 0°, 45°, 90°, 135° meridians after full dilation. The highest quality image of each meridian was selected and then transferred to an online computer. The axial densitometry of the computer was used to calculate the scatter light density of the central 3-mm area of the posterior capsule and the IOL of the same-size area. The density value was expressed in computer-compatible tape steps (CCT). The density value in 1 section was determined by subtracting the scatter light density in the IOL from the measured value in the posterior capsule. The averaged density values of the 4 meridians were considered to be the PCO value. All measurements were performed by 3 ophthalmic technicians who were not aware of the aims of the study.
The visual acuity of these patients was determined using the decimal charts at all postoperative visits. The decline in corrected visual acuity from the best postoperative acuity at the visit either for the PCO measurement or the Nd:YAG laser capsulotomy was statistically compared between the 3 groups.
Statistical analyses were performed to compare the differences between the 3 groups using the χ2 test for categorical variables and the Scheffé F test for continuous variables. Any differences at P<.05 were determined to be statistically significant.
Of the 240 enrolled eyes, 28 were lost to follow-up. Therefore, 212 eyes remained for the analysis. The patient demographics are shown in Table 1. The mean ± SD patient age was 68.9 ± 9.1 years with a range of 52 to 93 years, and the patients included 88 men and 124 women. No statistically significant differences were found regarding age, sex, or the ratio of the left and right eyes between the 3 groups. In the first examination, after a full mydriasis at 1 week after surgery, all IOLs were confirmed to be accurately implanted in the capsular bag.
Of the 212 eyes, 21 eyes (30.4%) in the PMMA group, 4 (5.7%) in the silicone group, and 2 (2.7%) in the acrylic group had already undergone an Nd:YAG laser posterior capsulotomy before undergoing the PCO measurement (Table 2). The Nd:YAG capsulotomy rate in the PMMA group was significantly greater than that in the silicone or acrylic group (P<.001, χ2 test). No significant difference was found regarding the average interval between cataract surgery and Nd:YAG laser capsulotomy between the 3 groups.
The number of eyes that underwent the PCO measurement totaled 48 in the PMMA group, 66 in the silicone group, and 71 in the soft acrylic group (Figure 1). Table 2 summarizes the mean PCO value of the 3 groups. The data are also displayed in Figure 2. The mean PCO value in the PMMA group was significantly greater than that in the silicone or soft acrylic group (P<.001, Scheffé test). In addition, the mean PCO value in the silicone group was smaller than that in the acrylic group, but the difference was not significant (P=.08).
Table 3 lists the visual acuity loss from the best postoperative acuity of the 3 groups. The visual acuity loss in the PMMA group was greater than that in the silicone or acrylic group (P<.001, χ2 test). The difference between the silicone and soft acrylic group was not significant.
An objective quantification method of PCO has yet to be established up to now. Although many systems using retroillumination photography have been developed, an indirect retroillumination image is unavoidably influenced by an uneven background illumination.25-27 In addition, these systems are considered to be unable to measure the density of capsular fibrosis and multilayered lens epithelial cells. We recently developed a new method using an axial densitometry of the Scheimpflug videophotography system to directly calculate the opacification density of the posterior capsule.15 Since the measured PCO value showed a good correlation with the patient's visual acuity, this method is considered to be useful for the clinical evaluation of PCO.
Previous studies have shown the occurrence of PCO to differ based on the optic material of the implanted IOL.17-19,21 The low incidence of PCO in eyes with a soft acrylic IOL has recently been reported.21 On the other hand, the Nd:YAG posterior capsulotomy rates with the silicone IOL vary considerably among the published studies.28-33 Steinert and associates32 attributed the recent reduction in the Nd:YAG capsulotomy rate of the silicone IOL to improvements in the implant techniques. We also experienced a high incidence of capsular fibrosis due to the optic capture at the beginning of the silicone lens implantation.34 These results indicate that the occurrence of PCO after the silicone IOL implantation therefore substantially depends on the IOL fixation technique. This study demonstrated the density of PCO with the PMMA IOL to be much greater than that with either silicone or soft acrylic IOLs (P<.001). In addition, the Nd:YAG capsulotomy rate in the PMMA group was also higher than for either the silicone or soft acrylic IOL group (P<.001). On the other hand, the PCO value with silicone IOL was also smaller than that with soft acrylic IOL, but the difference was marginal. In the present series, all IOLs were placed in the capsular bag and the design of the 3 IOLs was also similar. Therefore, the greater degree of PCO with the PMMA IOL is thus attributable to the optic material itself.
Why is the extent of PCO slighter with the silicone or soft acrylic IOL than that with the PMMA IOL? In cases of complete capsular fixation, in which the lens optic edge is circumferentially covered by the anterior capsule, the extent of PCO is mainly dependent on the regenerated lens epithelial cell proliferation in the retrolental space.19,35,36 Since the acrylic optic is supposed to adhere firmly to the lens capsule,22,23 we assumed that the regenerated lens epithelial cells may thus be unable to easily invade this space.36 On the other hand, there is no reasonable explanation for the decreased PCO observed with the silicone IOL. However, its mechanism must be different from that of the soft acrylic IOL since the silicone IOL does not have as strong of an adhesive quality as that of the soft acrylic IOL.23
The visual acuity loss due to PCO was significantly greater in the PMMA group than in the silicone or soft acrylic group, while no significant difference was observed between the silicone and acrylic groups. These findings also supported the occurrence of extensive PCO in the eyes that received PMMA IOL implantation. In contrast, the eyes that underwent either silicone or soft acrylic IOL implantation maintained a substantially good visual acuity even approximately 2 years after surgery.
In conclusion, this quantitative study clarified that the degree of PCO in the eyes with the PMMA IOL was considerably more extensive than that with either the silicone or soft acrylic IOL. This finding may lead surgeons to select foldable IOLs over PMMA IOLs.37,38 However, the difference between the silicone and the soft acrylic IOLs were not conclusive in this study. Furthermore, the baseline data and periodic changes of PCO could not be demonstrated in this study. As a result, a further prospective study is clearly needed to obtain a better understanding of PCO.
Accepted for publication July 17, 1998.
Presented in part at the XVI Congress of the European Society of Cataract and Refractive Surgeons meeting, Nice, France, September 6-9, 1998.
Reprints: Hideyuki Hayashi, MD, Department of Ophthalmology, School of Medicine, Fukuoka University, 7-45-1 Nanakuma. Jonan-Ku, Fukuoka 812, Japan (e-mail: firstname.lastname@example.org).
et al. Posterior capsule opacification. Surv Ophthalmol.
1992;3773- 116Google ScholarCrossref
WR Posterior capsule opacification in pseudophakic eyes. Ophthalmology.
1983;901548- 1553Google ScholarCrossref
WR Posterior capsule opacification: a specular microscopic study. Ophthalmology.
1984;91853- 856Google ScholarCrossref
G Pathogenesis of capsular opacification after extracapsular cataract extraction: an animal model. Ophthalmology.
1984;91857- 863Google ScholarCrossref
B An ultrastructual study of Elschnig's pearls in the pseudophakic eyes. Am J Ophthalmol.
1986;10158- 69Google Scholar
E A histologic study of lens degeneration in aphakic rabbits. Invest Ophthalmol Vis Sci.
1990;31540- 547Google Scholar
T Apoptotic cell death in rabbit lens after lens extraction. Invest Ophthalmol Vis Sci.
1997;382322- 2330Google Scholar
JM Mitotic inhibitors in preventing posterior capsule opacification: 2.5-year follow-up. Emery
ACeds. Current Concepts in Cataract Surgery: Selected Proceedings of the Eighth Biennial Cataract Surgical Congress.
St Louis, Mo Mosby–Year Book Inc1984;303- 312Google Scholar
JL Inhibition of posterior capsule opacification by 5-fluorouracil in rabbits. Ophthalmic Res.
1990;22201- 208Google ScholarCrossref
SL Inhibition of posterior capsule opacification: the effect of colchicine in a sustained drug delivery system. J Cataract Refract Surg.
1993;19462- 470Google ScholarCrossref
O Effect of intraocular sustained release of indomethacin on postoperative inflammation and posterior capsule opacification. J Cataract Refract Surg.
1996;22(suppl)806- 810Google ScholarCrossref
HE Inhibition of posterior capsule opacification by an intraocular lens-bound sustained drug delivery system. J Cataract Refract Surg.
1996;221070- 1078Google ScholarCrossref
AL Mitomycin against posterior capsule opacification: an experimental study in rabbits. Br J Ophthalmol.
1996;801087- 1091Google ScholarCrossref
I Inhibition of migrating lens epithelial cells by blocking the adhesion molecule integrin: a preliminary report. J Cataract Refract Surg.
1997;23860- 865Google ScholarCrossref
F In vivo quantitative measurement of posterior capsule opacification after extracapsular cataract surgery. Am J Ophthalmol.
1998;125837- 843Google ScholarCrossref
F Reproducibility of posterior capsule opacification measurement using Scheimpflug videophotography system. J Cataract Refract Surg.
In press.Google Scholar
Jr Lens epithelial inhibition by PMMA optic: implications for lens design. J Cataract Refract Surg.
1986;1223- 26Google ScholarCrossref
AT Posterior capsule opacification after silicone lens implantation and its management. J Cataract Refract Surg.
1987;13644- 648Google ScholarCrossref
R Posterior capsule opacification and capsulotomy rates with taco-style hydrogel intraocular lenses. J Cataract Refract Surg.
1996;22(suppl)1318- 1330Google ScholarCrossref
DJ The incidence of posterior capsule opacification with PMMA, AcrySof and silicone IOLs: 3-year results. Presented at: XVth European Society of Cataract and Refractive Surgeons Congress September 7-10, 1997 Prague, Czech Republic.
S Two years' clinical study of a soft acrylic intraocular lens. J Cataract Refract Surg.
1996;22104- 109Google ScholarCrossref
I Adhesiveness of a soft acrylic intraocular lens to a collagen film. J Cataract Refract Surg.
1998;24367- 370Google ScholarCrossref
Y Adhesion of lens capsule to intraocular lenses of polymethylmethacrylate, silicone, and acrylic foldable materials: an experimental study. Br J Ophthalmol.
1998;82549- 553Google ScholarCrossref
F The correlation between incision size and corneal shape changes in sutureless cataract surgery. Ophthalmology.
1995;102550- 556Google ScholarCrossref
C Quantitative analysis of after-cataracts. J Eye.
1992;91588- 1592Google Scholar
HE Photographic image analysis system of posterior capsule opacification. J Cataract Refract Surg.
1997;231515- 1520Google ScholarCrossref
S High-resolution digital retroillumination imaging of the posterior lens capsule after cataract surgery. J Cataract Refract Surg.
1997;231521- 1527Google ScholarCrossref
AM Initial clinical studies with silicone intraocular implants. J Cataract Refract Surg.
1988;14294- 298Google ScholarCrossref
et al. Comparative study of intraocular lens implantation through 3.2- and 5.5-mm incisions. Ophthalmology.
1994;1011183- 1190Google ScholarCrossref
R Evaluation of 35 consecutive SI-30 PhacoFlex lenses with high-refractive silicone optic implanted in the capsulorhexis bag. J Cataract Refract Surg.
1995;21339- 347Google ScholarCrossref
et al. Prospective study of 210 consecutive cases of endocapsular phacoemulsification using the AMO SI-30NB 3-piece foldable lens. Aust N Z J Ophthalmol.
1995;23387- 391Google ScholarCrossref
VA Clinical assessment of long-term safety and efficacy of a widely implanted silicone intraocular lens material. Am J Ophthalmol.
1997;12317- 23Google Scholar
RJ Neodymium:YAG capsulotomy rates after phacoemulsification with silicone posterior chamber intraocular lenses. J Cataract Refract Surg.
1996;22(suppl)1296- 1302Google ScholarCrossref
F Capsular capture of silicone intraocular lenses. J Cataract Refract Surg.
1996;22(suppl)1267- 1271Google ScholarCrossref
F Capsulorhexis size and posterior capsule opacification. J Cataract Refract Surg.
1996;2298- 103Google ScholarCrossref
RJ Sandwich theory: bioactive-based explanation for posterior capsule opacification. J Cataract Refract Surg.
1997;231539- 1542Google ScholarCrossref
DV Practice styles and preferences of ASCRS members–1996 survey. J Cataract Refract Surg.
1997;23527- 535Google ScholarCrossref
DV Current trends in cataract and refractive surgery in Japan: 1996 survey. Jpn J Ophthalmol.
1998;42227- 241Google ScholarCrossref